Sabha Mushtaq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sabha Mushtaq has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Devraj Dogra
Department of Dermatology, Venereology & Leprology, Government Medical College, Jammu, University of Jammu , J&K
6 shared publicationsNaina Dogra
Department of Dermatology, Venereology & Leprology, Government Medical College, Jammu, University of Jammu , J&K
5 shared publicationsGunjan Gupta
Department of Dermatology, Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttarakhand, India
3 shared publications- Nafis Faizi
Department of Community Medicine, Jawaharlal Nehru Medical College & Hospital, Aligarh Muslim University (AMU), Aligarh, India
3 shared publications - Mohammad Adil
Department of Dermatology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India
2 shared publications Mohammad Mohtashim
Department of Dermatology, Jawaharlal Nehru Medical College, Aligarh, Uttar Pradesh, India
2 shared publications
Latest Publications
- 18 March 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (8) , 1458-1465
Safety and efficacy of intralesional Amphotericin B in the treatment of Old World Cutaneous Leishmaniasis: A non-randomized open-label prospective study
Background: Cutaneous leishmaniasis (CL) is a neglected tropical disease with limited accessible treatment options. While pentavalent antimonials remain the gold standard, emergence of drug resistance and recurrent stockouts pose significant challenges. Amphotericin B is a well-established treatment of visceral leishmaniasis; however, its use in Old World CL (OWCL), particularly via intralesional route and using conventional formulations has been studied only anecdotally. Objectives: To evaluate the safety and efficacy of intralesional Amp B deoxycholate in treatment of OWCL. Methods: A non-randomized prospective study was conducted to evaluate the safety and efficacy of intralesional amphotericin B in OWCL. All treatment naïve cases of CL with ≤5 skin lesions were included. Amphotericin B deoxycholate (2.5 mg/ml) was administered intralesionally at weekly intervals for up to 8 weeks, or until a complete clinical response, whichever occurred first. Treatment response was assessed at 4, 8 and 12 weeks. Treatment responders were followed for 6 months to record recurrence. Results: A total of 50 patients with 61 skin lesions were included in the analysis. At 12 weeks, 44 (88%) patients showed complete response and the overall cure rate was 96%. Treatment response was not affected by the disease duration, lesion site or morphology. All treatment responders remained recurrence-free at the 6-months follow up. Reported side effects were mild and self -limiting. Conclusion: Intralesional amphotericin B deoxycholate was found to be effective and safe in the treatment of OWCL. The study is limited by the small sample size, lack of a control group and non-availability of species typing.
- 18 March 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (8) , 1458-1465
Safety and efficacy of intralesional Amphotericin B in the treatment of Old World Cutaneous Leishmaniasis: A non-randomized open-label prospective study
Background: Cutaneous leishmaniasis (CL) is a neglected tropical disease with limited accessible treatment options. While pentavalent antimonials remain the gold standard, emergence of drug resistance and recurrent stockouts pose significant challenges. Amphotericin B is a well-established treatment of visceral leishmaniasis; however, its use in Old World CL (OWCL), particularly via intralesional route and using conventional formulations has been studied only anecdotally. Objectives: To evaluate the safety and efficacy of intralesional Amp B deoxycholate in treatment of OWCL. Methods: A non-randomized prospective study was conducted to evaluate the safety and efficacy of intralesional amphotericin B in OWCL. All treatment naïve cases of CL with ≤5 skin lesions were included. Amphotericin B deoxycholate (2.5 mg/ml) was administered intralesionally at weekly intervals for up to 8 weeks, or until a complete clinical response, whichever occurred first. Treatment response was assessed at 4, 8 and 12 weeks. Treatment responders were followed for 6 months to record recurrence. Results: A total of 50 patients with 61 skin lesions were included in the analysis. At 12 weeks, 44 (88%) patients showed complete response and the overall cure rate was 96%. Treatment response was not affected by the disease duration, lesion site or morphology. All treatment responders remained recurrence-free at the 6-months follow up. Reported side effects were mild and self -limiting. Conclusion: Intralesional amphotericin B deoxycholate was found to be effective and safe in the treatment of OWCL. The study is limited by the small sample size, lack of a control group and non-availability of species typing.
- Open Access
- 22 November 2024
- Published by Instituto Lauro de Souza Lima in Hansenologia Internationalis
- Vol. 49, 1-7
Hyperpigmented macules surrounded by hypopigmented rim in a case of lepromatous leprosy
Introduction: leprosy is a chronic infectious mycobacterial disease caused by M. leprae. It primarily involves the skin and nerves, presenting with skin lesions and nerve enlargement. The skin lesions vary from hypopigmented, anesthetic macules/plaques to erythematous papules, plaques, and nodules, depending upon the type of leprosy.Hyperpigmented lesions in leprosy are rarely reported. Although hypopigmented lesions are commonly seen, perilesional hypopigmentation is a rare occurrence in leprosy. Perilesional hypopigmentation is seen as Woronoff’s ring around resolving lesions of psoriasis. A similar phenomenon called the halo phenomenon is associated with various skin tumors. Case Presentation: we describe a rare presentation of a leprosy case presenting with hyperpigmented lesions surrounded by a perilesional hypopigmented rim.
- 22 November 2024
- Published by Instituto Lauro de Souza Lima in Hansenologia Internationalis
- Vol. 49, 1-7
Open AccessHyperpigmented macules surrounded by hypopigmented rim in a case of lepromatous leprosy
Introduction: leprosy is a chronic infectious mycobacterial disease caused by M. leprae. It primarily involves the skin and nerves, presenting with skin lesions and nerve enlargement. The skin lesions vary from hypopigmented, anesthetic macules/plaques to erythematous papules, plaques, and nodules, depending upon the type of leprosy.Hyperpigmented lesions in leprosy are rarely reported. Although hypopigmented lesions are commonly seen, perilesional hypopigmentation is a rare occurrence in leprosy. Perilesional hypopigmentation is seen as Woronoff’s ring around resolving lesions of psoriasis. A similar phenomenon called the halo phenomenon is associated with various skin tumors. Case Presentation: we describe a rare presentation of a leprosy case presenting with hyperpigmented lesions surrounded by a perilesional hypopigmented rim.
- Open Access
- 10 October 2024
- Published by Instituto Lauro de Souza Lima in Hansenologia Internationalis
- Vol. 49, 1-7
Erythematous lesions with Woronoff’s ring like perilesional hypopigmented halo in a case of leprosy
Introduction: leprosy, a chronic infectious mycobacterial disease caused by M. leprae, presents with a broad spectrum of skin lesions depending upon the type of leprosy. Woronoff’s ring, a hypopigmented halo, is classically observed around resolving psoriatic lesions and is also seen in association with various skin tumors. However, such a phenomenon is rarely reported in leprosy. Objective: to describe an atypical case of borderline lepromatous leprosy presenting with Woronoff’s ringlike perilesional hypopigmented halo. Case description: the report describes a case of borderline lepromatous leprosy with multiple erythematous lesions over the face, each surrounded by a ring of hypopigmentation. Slit skin smear was positive for acid-fast bacilli, and skin biopsy taken from the facial macular lesion was consistent with the diagnosis. The patient was put on WHO-recommended multibacillary multidrug therapy. Discussion: perilesional hypopigmentation, typically associated with psoriatic lesions and certain skin tumors, has rarely been reported in leprosy. The present case was unique due to erythematous lesions with a perilesional hypopigmented halo over the face. Such unusual presentation can lead to a diagnostic dilemma and delay in diagnosis and treatment. Previous literature reports similar findings in isolated cases, suggesting defective melanin transfer or nerve damage as possible causes. Final consideration: leprosy can present with atypical manifestations that often pose a diagnostic dilemma. This case emphasizes the importance of comprehensive clinical and cutaneous examination and maintaining a high index of suspicion for leprosy in patients with unusual skin lesions. Timely diagnosis and treatment are crucial to break the chain of transmission in the community.
- 10 October 2024
- Published by Instituto Lauro de Souza Lima in Hansenologia Internationalis
- Vol. 49, 1-7
Open AccessErythematous lesions with Woronoff’s ring like perilesional hypopigmented halo in a case of leprosy
Introduction: leprosy, a chronic infectious mycobacterial disease caused by M. leprae, presents with a broad spectrum of skin lesions depending upon the type of leprosy. Woronoff’s ring, a hypopigmented halo, is classically observed around resolving psoriatic lesions and is also seen in association with various skin tumors. However, such a phenomenon is rarely reported in leprosy. Objective: to describe an atypical case of borderline lepromatous leprosy presenting with Woronoff’s ringlike perilesional hypopigmented halo. Case description: the report describes a case of borderline lepromatous leprosy with multiple erythematous lesions over the face, each surrounded by a ring of hypopigmentation. Slit skin smear was positive for acid-fast bacilli, and skin biopsy taken from the facial macular lesion was consistent with the diagnosis. The patient was put on WHO-recommended multibacillary multidrug therapy. Discussion: perilesional hypopigmentation, typically associated with psoriatic lesions and certain skin tumors, has rarely been reported in leprosy. The present case was unique due to erythematous lesions with a perilesional hypopigmented halo over the face. Such unusual presentation can lead to a diagnostic dilemma and delay in diagnosis and treatment. Previous literature reports similar findings in isolated cases, suggesting defective melanin transfer or nerve damage as possible causes. Final consideration: leprosy can present with atypical manifestations that often pose a diagnostic dilemma. This case emphasizes the importance of comprehensive clinical and cutaneous examination and maintaining a high index of suspicion for leprosy in patients with unusual skin lesions. Timely diagnosis and treatment are crucial to break the chain of transmission in the community.
- Open Access
- 2 October 2024
- Published by Instituto Lauro de Souza Lima in Hansenologia Internationalis
- Vol. 49, 1-8
Ulcerative type 1 lepra reaction in borderline-tuberculoid leprosy
Introduction: leprosy is a chronic infectious disease caused by Mycobacterium leprae, characterized by a wide spectrum of clinical presentations. In India, borderline-tuberculoid leprosy is the most common form encountered in clinical practice. Type 1 lepra reaction in borderline- uberculoid leprosy usually presents as the development of erythema and/or edema in pre-existing skin lesions. Ulceration of skin lesions in type 1 lepra reaction is uncommon and occurs in severe reactions. Objective: to report an unusual presentation of borderline-tuberculoid leprosy with ulcerative type 1 lepra reaction in an immunocompetent patient. Case description: we present the case of a 65-yearold man with chief complaints of ulcerated plaque over his left thigh. He also had other skin lesions suggestive of borderline-tuberculoid leprosy over his trunk and limbs, as well asenlarged, mildly tender left ulnar and lateral popliteal nerves. A slit skin smear was negative, while a skin biopsy supported the diagnosis of borderline-tuberculoid leprosy. The patient responded to multibacillary multidrug therapy according recommended by World Health Organization and tapering doses of prednisolone, with complete healing of the ulceration at six weeks follow-up. Discussion: type 1 lepra reaction associated with borderline-tuberculoid leprosy usually presents with increased erythema and edema in pre-existing skin lesions. Ulceration in such skin lesions is not commonly seen except in cases with severe type 1 leprosy reactions. Administration of oral corticosteroids along with multibacillary multidrug therapy is the key to managing ulcerative type 1 lepra reaction. The ulceration heals rapidly with tapering doses of oral corticosteroids, limiting the duration of morbidity. Final consideration: the case emphasizes the need for dermatologists and leprologists to be aware of atypical presentations of leprosy reactions, ensuring timely diagnosis and effective management to achieve optimal patient outcomes.
- 2 October 2024
- Published by Instituto Lauro de Souza Lima in Hansenologia Internationalis
- Vol. 49, 1-8
Open AccessUlcerative type 1 lepra reaction in borderline-tuberculoid leprosy
Introduction: leprosy is a chronic infectious disease caused by Mycobacterium leprae, characterized by a wide spectrum of clinical presentations. In India, borderline-tuberculoid leprosy is the most common form encountered in clinical practice. Type 1 lepra reaction in borderline- uberculoid leprosy usually presents as the development of erythema and/or edema in pre-existing skin lesions. Ulceration of skin lesions in type 1 lepra reaction is uncommon and occurs in severe reactions. Objective: to report an unusual presentation of borderline-tuberculoid leprosy with ulcerative type 1 lepra reaction in an immunocompetent patient. Case description: we present the case of a 65-yearold man with chief complaints of ulcerated plaque over his left thigh. He also had other skin lesions suggestive of borderline-tuberculoid leprosy over his trunk and limbs, as well asenlarged, mildly tender left ulnar and lateral popliteal nerves. A slit skin smear was negative, while a skin biopsy supported the diagnosis of borderline-tuberculoid leprosy. The patient responded to multibacillary multidrug therapy according recommended by World Health Organization and tapering doses of prednisolone, with complete healing of the ulceration at six weeks follow-up. Discussion: type 1 lepra reaction associated with borderline-tuberculoid leprosy usually presents with increased erythema and edema in pre-existing skin lesions. Ulceration in such skin lesions is not commonly seen except in cases with severe type 1 leprosy reactions. Administration of oral corticosteroids along with multibacillary multidrug therapy is the key to managing ulcerative type 1 lepra reaction. The ulceration heals rapidly with tapering doses of oral corticosteroids, limiting the duration of morbidity. Final consideration: the case emphasizes the need for dermatologists and leprologists to be aware of atypical presentations of leprosy reactions, ensuring timely diagnosis and effective management to achieve optimal patient outcomes.
- Open Access
- 1 July 2024
- Published by Wolters Kluwer Health in Indian Journal of Paediatric Dermatology
- Vol. 25 (3) , 253-254
Fragile Hair and Alopecia in a Young Female Child: A Rare Case of Isolated Congenital Trichorrhexis Nodosa
- 1 July 2024
- Published by Wolters Kluwer Health in Indian Journal of Paediatric Dermatology
- Vol. 25 (3) , 253-254
Open AccessFragile Hair and Alopecia in a Young Female Child: A Rare Case of Isolated Congenital Trichorrhexis Nodosa
- 1 January 2024
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 111 (3) , 179-185
A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India
- 1 January 2024
- Published by Termedia Sp. z.o.o. in Dermatology Review
- Vol. 111 (3) , 179-185
A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India
- 22 January 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (6) , E350-E351
Ulcerated cutaneous lesions in type 1 lepra reaction healing with morpheaform scarring: an unusual presentation
- 22 January 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (6) , E350-E351
Ulcerated cutaneous lesions in type 1 lepra reaction healing with morpheaform scarring: an unusual presentation
- Open Access
- 1 January 2023
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 14 (5) , 741-742
Blonde hair heterochromia over a background of black scalp hair in an Indian child
- 1 January 2023
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 14 (5) , 741-742
Open AccessBlonde hair heterochromia over a background of black scalp hair in an Indian child
- Open Access
- 1 January 2023
- Published by Medknow in Indian Journal of Paediatric Dermatology
- Vol. 24 (1) , 97-98
Ectodermal Dysplasia-Skin Fragility Syndrome in an Infant
- 1 January 2023
- Published by Medknow in Indian Journal of Paediatric Dermatology
- Vol. 24 (1) , 97-98
Open AccessEctodermal Dysplasia-Skin Fragility Syndrome in an Infant
- Open Access
- 1 January 2023
- Published by Medknow in Indian Journal of Paediatric Dermatology
- Vol. 24 (1) , 79-80
Annular Erythema of Infancy in a Neonate
- 1 January 2023
- Published by Medknow in Indian Journal of Paediatric Dermatology
- Vol. 24 (1) , 79-80
Open AccessAnnular Erythema of Infancy in a Neonate